{"title": "'Startup like no other': China's Hengrui launches Luzsana with Big Pharma veterans at the top and a goal to improve drug access", "author": "Angus Liu", "url": "https://www.fiercepharma.com/pharma/startup-no-other-chinas-hengrui-launches-luzsana-big-pharma-veterans-top-and-goal-improve", "hostname": "fiercepharma.com", "description": "After 50 years establishing itself as one of the largest pharma companies in China, Jiangsu Hengrui Pharmaceuticals is launching Luzsana Biotechnology targeted at the global market. | After 50 years establishing itself as one of the largest pharma companies in China, Jiangsu Hengrui Pharmaceuticals is launching Luzsana Biotechnology for the global market. With a unique operating model, the subsidiary aims to \"quantifiably reduce costs\" of medicines, its CEO said, starting with a PD-1 cancer immunotherapy.", "sitename": "FiercePharma", "date": "2022-05-18", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}